+499.5%
MRNA vs KRMN
-25.5%
+525.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | KRMN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.3% | -0.9% | -1.9% |
| 7D | +5.5% | -12.3% | +17.7% | +8.8% |
| 30D | +158.7% | -27.5% | +186.2% | +179.1% |
| 3M | +182.1% | -26.5% | +208.6% | +200.9% |
| 6M | +151.8% | -59.6% | +211.4% | +210.8% |
| YTD | +393.6% | -45.4% | +438.9% | +443.6% |
| 1Y | +499.5% | -25.1% | +524.6% | +491.7% |
| All | +499.5% | -25.5% | +525.0% | +491.7% |
Cumulative growth
Daily Returns
Daily percentage return beside KRMN.
Daily Out/Under-Performance
Portfolio return minus KRMN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × KRMN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded KRMN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling